Protein kinases of Toxoplasma gondii: Functions and drug targets

Parasitology Research

Volumn 112, Issue 6, 2013, Pages 2121-2129

  Wei, Feng ^a   Wang, Wei ^b   Liu, Quan ^b  

^a JILIN AGRICULTURAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; BENZIMIDAZOLE DERIVATIVE; BENZOYLBENZIMIDAZOLE DERIVATIVE; CALCIUM DEPENDENT PROTEIN KINASE 1; CALCIUM DEPENDENT PROTEIN KINASE 2; CASEIN KINASE; CASEIN KINASE IALPHA; CASEIN KINASE IBETA; CASEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR; FR 180204; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MUTANT PROTEIN; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PROTEIN ROP16; PROTEIN ROP18; PROTEIN ROP2; PROTEIN ROP4; PROTEIN ROP5; PROTEIN ROP7; PURVALANOL B; PYRIDINYLIMIDAZOLE; RHOPTRY KINASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BRADYZOITE; CELL CYCLE REGULATION; DRUG EFFICACY; DRUG SAFETY; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME STRUCTURE; EYE DISEASE; HOST PARASITE INTERACTION; HUMAN; IMMUNOCOMPROMISED PATIENT; NEUROLOGIC DISEASE; NONHUMAN; OPPORTUNISTIC INFECTION; PARASITE DEVELOPMENT; PARASITE TRANSMISSION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANTIPROTOZOAL AGENTS; DRUG DISCOVERY; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; TOXOPLASMA;

ANIMALIA; MAMMALIA; TOXOPLASMA GONDII;

EID: 84878687428     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-013-3451-y     Document Type: Review

References (76)

1. Behnke MS, Khan A, Wootton JC, Dubey JP, Tang K, Sibley LD (2011) Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc Natl Acad Sci USA 108:9631-9636
2. Brumlik MJ, Wei S, Finstad K, Nesbit J, Hyman LE, Lacey M, Burow ME, Curiel TJ (2004) Identification of a novel mitogen-activated protein kinase in Toxoplasma gondii. Int J Parasitol 34:1245-1254
3. Butcher BA, Fox BA, Rommereim LM, Kim SG, Maurer KJ, Yarovinsky F, Herbert DR, Bzik DJ, Denkers EY (2011) Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog 7:e1002236
4. Carey KL, Jongco AM, Kim K, Ward GE (2004) The Toxoplasma gondii rhoptry protein ROP4 is secreted into the parasitophorous vacuole and becomes phosphorylated in infected cells. Eukaryot Cell 3:1320-1330
5. Chardes T, Bourguin I, Mevelec MN, Dubremetz JF, Bout D (1990) Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens. Infect Immun 58:1240-1246
6. Cuevas BD, Abell AN, Johnson GL (2007) Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 26:3159-3171
7. Denkers EY, Bzik DJ, Fox BA, Butcher BA (2012) An inside job: hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii. Infect Immun 80:476-482
8. Donald RG, Allocco J, Singh SB, Nare B, Salowe SP, Wiltsie J, Liberator PA (2002) Toxoplasma gondii cyclic GMP-dependent kinase: chemotherapeutic targeting of an essential parasite protein kinase. Eukaryot Cell 1:317-328
9. Donald RG, Liberator PA (2002) Molecular characterization of a coccidian parasite cGMP dependent protein kinase. Mol Biochem Parasitol 120:165-175
10. Donald RG, Zhong T, Meijer L, Liberator PA (2005) Characterization of two T. gondii CK1 isoforms. Mol Biochem Parasitol 141:15-27
11. Donald RG, Zhong T, Wiersma H, Nare B, Yao D, Lee A, Allocco J, Liberator PA (2006) Anticoccidial kinase inhibitors: identification of protein kinase targets secondary to cGMP-dependent protein kinase. Mol Biochem Parasitol 149:86-98
12. El Hajj H, Demey E, Poncet J, Lebrun M, Wu B, Galeotti N, Fourmaux MN, Mercereau-Puijalon O, Vial H, Labesse G, Dubremetz JF (2006) The ROP2 family of Toxoplasma gondii rhoptry proteins: proteomic and genomic characterization and molecular modeling. Proteomics 6:5773-5784
13. El Hajj H, Lebrun M, Arold ST, Vial H, Labesse G, Dubremetz JF (2007a) ROP18 is a rhoptry kinase controlling the intracellular proliferation of Toxoplasma gondii. PLoS Pathog 3:e14
14. El Hajj H, Lebrun M, Fourmaux MN, Vial H, Dubremetz JF (2007b) Inverted topology of the Toxoplasma gondii ROP5 rhoptry protein provides new insights into the association of the ROP2 protein family with the parasitophorous vacuole membrane. Cell Microbiol 9:54-64
15. Fentress SJ, Sibley LD (2011) The secreted kinase ROP18 defends Toxoplasma's border. Bioessays 33:693-700
16. Fentress SJ, Steinfeldt T, Howard JC, Sibley LD (2012) The arginine-rich N-terminal domain of ROP18 is necessary for vacuole targeting and virulence of Toxoplasma gondii. Cell Microbiol 14:1921-1933
17. Fleckenstein MC, Reese ML, Konen-Waisman S, Boothroyd JC, Howard JC, Steinfeldt T (2012) A Toxoplasma gondii pseudokinase inhibits host IRG resistance proteins. PLoS Biol 10:e1001358
18. Gatkowska J, Wieczorek M, Dziadek B, Dzitko K, Dlugonska H (2012) Behavioral changes in mice caused by Toxoplasma gondii invasion of brain. Parasitol Res 111:53-58
19. Gross SD, Anderson RA (1998) Casein kinase I: spatial organization and positioning of a multifunctional protein kinase family. Cell Signal 10:699-711
20. Hajj HE, Lebrun M, Fourmaux MN, Vial H, Dubremetz JF (2006) Characterization, biosynthesis and fate of ROP7, a ROP2 related rhoptry protein of Toxoplasma gondii. Mol Biochem Parasitol 146:98-100
21. Hanks SK, Hunter T (1995) Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 9:576-596
22. Harper JF, Harmon A (2005) Plants, symbiosis and parasites: a calcium signalling connection. Nat Rev Mol Cell Biol 6:555-566
23. Hegab SM, Al-Mutawa SA (2003) Immunopathogenesis of toxoplasmosis. Clin Exp Med 3:84-105
24. Hill D, Dubey JP (2002) Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect 8:634-640
25. Hill DE, Chirukandoth S, Dubey JP (2005) Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev 6:41-61
26. Huang H, Ma YF, Bao Y, Lee H, Lisanti MP, Tanowitz HB, Weiss LM (2011) Molecular cloning and characterization of mitogen-activated protein kinase 2 in Toxoplasma gondii. Cell Cycle 10:3519-3526
27. Johnson SM, Murphy RC, Geiger JA, DeRocher AE, Zhang Z, Ojo KK, Larson ET, Perera BG, Dale EJ, He P, Reid MC, Fox AM, Mueller NR, Merritt EA, Fan E, Parsons M, Van Voorhis WC, Maly DJ (2012) Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity. J Med Chem 55:2416-2426
28. Jost C, Reiter-Owona I, Liesenfeld O (2007) The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice. Parasitol Res 101:1603-1609
29. Khan F, Tang J, Qin CL, Kim K (2002) Cyclin-dependent kinase TPK2 is a critical cell cycle regulator in Toxoplasma gondii. Mol Microbiol 45:321-332
30. Kieschnick H, Wakefield T, Narducci CA, Beckers C (2001) Toxoplasma gondii attachment to host cells is regulated by a calmodulin-like domain protein kinase. J Biol Chem 276:12369-12377
31. Knockaert M, Gray N, Damiens E, Chang YT, Grellier P, Grant K, Fergusson D, Mottram J, Soete M, Dubremetz JF, Le Roch K, Doerig C, Schultz P, Meijer L (2000) Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. Chem Biol 7:411-422
32. Kurokawa H, Kato K, Iwanaga T, Sugi T, Sudo A, Kobayashi K, Gong H, Takemae H, Recuenco FC, Horimoto T, Akashi H (2011) Identification of Toxoplasma gondii cAMP dependent protein kinase and its role in the tachyzoite growth. PLoS One 6:e22492
33. Labesse G, Gelin M, Bessin Y, Lebrun M, Papoin J, Cerdan R, Arold ST, Dubremetz JF (2009) ROP2 from Toxoplasma gondii: a virulence factor with a protein-kinase fold and no enzymatic activity. Structure 17:139-146
34. Lacey MR, Brumlik MJ, Yenni RE, Burow ME, Curiel TJ (2007) Toxoplasma gondii expresses two mitogen-activated protein kinase genes that represent distinct protozoan subfamilies. J Mol Evol 64:4-14
35. Lam S, Tessler HH (1993) Quadruple therapy for ocular toxoplasmosis. Can J Ophthalmol 28:58-61
36. Larson ET, Ojo KK, Murphy RC, Johnson SM, Zhang Z, Kim JE, Leibly DJ, Fox AM, Reid MC, Dale EJ, Perera BG, Kim J, Hewitt SN, Hol WG, Verlinde CL, Fan E, Van Voorhis WC, Maly DJ, Merritt EA (2012) Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1. J Med Chem 55:2803-2810
37. Li S, Cui L, Zhao J, Dai P, Zong S, Zuo W, Chen C, Jin H, Gao H, Liu Q (2011) Seroprevalence of Toxoplasma gondii infection in female sterility patients in China. J Parasitol 97:529-530
38. Liu L, Liu T, Yu L, Cai Y, Zhang A, Xu X, Luo Q, Hu Y, Song W, Lun Z, Lu F, Wang Y, Shen J (2012) rROP2(186-533): a novel peptide antigen for detection of IgM antibodies against Toxoplasma gondii. Foodborne Pathog Dis 9:7-12
39. Lourido S, Shuman J, Zhang C, Shokat KM, Hui R, Sibley LD (2010) Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma. Nature 465:359-362
40. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298:1912-1934
41. Meijer L (2000) Cyclin-dependent kinases inhibitors as potential anticancer, antineurodegenerative, antiviral and antiparasitic agents. Drug Resist Updat 3:83-88
42. Miller SA, Thathy V, Ajioka JW, Blackman MJ, Kim K (2003) TgSUB2 is a Toxoplasma gondii rhoptry organelle processing proteinase. Mol Microbiol 49:883-894
43. Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965-1976
44. Moreno SN, Ayong L, Pace DA (2011) Calcium storage and function in apicomplexan parasites. Essays Biochem 51:97-110
45. Nakaar V, Ngo HM, Aaronson EP, Coppens I, Stedman TT, Joiner KA (2003) Pleiotropic effect due to targeted depletion of secretory rhoptry protein ROP2 in Toxoplasma gondii. J Cell Sci 116:2311-2320
46. Nare B, Allocco JJ, Liberator PA, Donald RG (2002) Evaluation of a cyclic GMP-dependent protein kinase inhibitor in treatment of murine toxoplasmosis: gamma interferon is required for efficacy. Antimicrob Agents Chemother 46:300-307
47. Nath A, Sinai AP (2003) Cerebral Toxoplasmosis. Curr Treat Options Neurol 5:3-12
48. Ngo HM, Yang M, Paprotka K, Pypaert M, Hoppe H, Joiner KA (2003) AP-1 in Toxoplasma gondii mediates biogenesis of the rhoptry secretory organelle from a post-Golgi compartment. J Biol Chem 278:5343-5352
49. Niedelman W, Gold DA, Rosowski EE, Sprokholt JK, Lim D, Farid Arenas A, Melo MB, Spooner E, Yaffe MB, Saeij JP (2012) The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog 8:e1002784
50. Ojo KK, Larson ET, Keyloun KR, Castaneda LJ, Derocher AE, Inampudi KK, Kim JE, Arakaki TL, Murphy RC, Zhang L, Napuli AJ, Maly DJ, Verlinde CL, Buckner FS, Parsons M, Hol WG, Merritt EA, Van Voorhis WC (2010) Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors. Nat Struct Mol Biol 17:602-607
51. Ong YC, Reese ML, Boothroyd JC (2010) Toxoplasma rhoptry protein 16 (ROP16) subverts host function by direct tyrosine phosphorylation of STAT6. J Biol Chem 285:28731-28740
52. Peixoto L, Chen F, Harb OS, Davis PH, Beiting DP, Brownback CS, Ouloguem D, Roos DS (2010) Integrative genomic approaches highlight a family of parasite-specific kinases that regulate host responses. Cell Host Microbe 8:208-218
53. Ramos JM, Milla A, Rodríguez JC, Padilla S, Masia M, Gutierrez F (2011) Seroprevalence of Toxoplasma gondii infection among immigrant and native pregnant women in Eastern Spain. Parasitol Res 109:1447-1452
54. Reese ML, Zeiner GM, Saeij JP, Boothroyd JC, Boyle JP (2011) Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc Natl Acad Sci USA 108:9625-9630
55. Reid AJ, Vermont SJ, Cotton JA, Harris D, Hill-Cawthorne GA, Konen-Waisman S, Latham SM, Mourier T, Norton R, Quail MA, Sanders M, Shanmugam D, Sohal A, Wasmuth JD, Brunk B, Grigg ME, Howard JC, Parkinson J, Roos DS, Trees AJ, Berriman M, Pain A, Wastling JM (2012) Comparative genomics of the apicomplexan parasites Toxoplasma gondii and Neospora caninum: Coccidia differing in host range and transmission strategy. PLoS Pathog 8:e1002567
56. Roisin MP, Robert-Gangneux F, Creuzet C, Dupouy-Camet J (2000) Biochemical characterization of mitogen-activated protein (MAP) kinase activity in Toxoplasma gondii. Parasitol Res 86:588-598
57. Saavedra R, de Meuter F, Decourt JL, Herion P (1991) Human T cell clone identifies a potentially protective 54-kDa protein antigen of Toxoplasma gondii cloned and expressed in Escherichia coli. J Immunol 147:1975-1982
58. Saavedra R, Becerril MA, Dubeaux C, Lippens R, De Vos MJ, Herion P, Bollen A (1996) Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii. Infect Immun 64:3858-3862
59. Sinai AP, Joiner KA (2001) The Toxoplasma gondii protein ROP2 mediates host organelle association with the parasitophorous vacuole membrane. J Cell Biol 154:95-108
60. Sugi T, Kato K, Kobayashi K, Kurokawa H, Takemae H, Gong H, Recuenco FC, Iwanaga T, Horimoto T, Akashi H (2011) 1NM-PP1 treatment of mice infected with Toxoplasma gondii. J Vet Med Sci 73:1377-1379
61. Sugi T, Kato K, Kobayashi K, Watanabe S, Kurokawa H, Gong H, Pandey K, Takemae H, Akashi H (2010) Use of the kinase inhibitor analog 1NM-PP1 reveals a role for Toxoplasma gondii CDPK1 in the invasion step. Eukaryot Cell 9:667-670
62. Sugi T, Kato K, Kobayashi K, Pandey K, Takemae H, Kurokawa H, Tohya Y, Akashi H (2009) Molecular analyses of Toxoplasma gondii calmodulin-like domain protein kinase isoform 3. Parasitol Int 58:416-423
63. Taylor SS, Buechler JA, Yonemoto W (1990) cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu Rev Biochem 59:971-1005
64. Thomas HV, Thomas DR, Salmon RL, Lewis G, Smith AP (2004) Toxoplasma and coxiella infection and psychiatric morbidity: a retrospective cohort analysis. BMC Psychiatry 4:32
65. Tzen M, Benarous R, Dupouy-Camet J, Roisin MP (2007) A novel Toxoplasma gondii calcium-dependent protein kinase. Parasite 14:141-147
66. Vermeulen AN (1998) Progress in recombinant vaccine development against coccidiosis. A review and prospects into the next millennium. Int J Parasitol 28:1121-1130
67. Wang H, Liu Q, Liu K, Zhong W, Gao S, Jiang L, An N (2007) Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol Int 56:263-268
68. Wastling JM, Kinnaird JH (1998) Isolation and characterisation of a genomic clone encoding a cdc2-related kinase of Toxoplasma gondii. Mol Biochem Parasitol 94:143-148
69. Wei S, Marches F, Daniel B, Sonda S, Heidenreich K, Curiel T (2002) Pyridinylimidazole p38 mitogen-activated protein kinase inhibitors block intracellular Toxoplasma gondii replication. Int J Parasitol 32:969-977
70. Wiersma HI, Galuska SE, Tomley FM, Sibley LD, Liberator PA, Donald RG (2004) A role for coccidian cGMP-dependent protein kinase in motility and invasion. Int J Parasitol 34:369-380
71. Yamamoto M, Takeda K (2012) Inhibition of ATF6beta-dependent host adaptive immune response by a Toxoplasma virulence factor ROP18. Virulence 3:77-80
72. Yamamoto M, Standley DM, Takashima S, Saiga H, Okuyama M, Kayama H, Kubo E, Ito H, Takaura M, Matsuda T, Soldati-Favre D, Takeda K (2009) A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3. J Exp Med 206:2747-2760
73. Yamamoto M, Ma JS, Mueller C, Kamiyama N, Saiga H, Kubo E, Kimura T, Okamoto T, Okuyama M, Kayama H, Nagamune K, Takashima S, Matsuura Y, Soldati-Favre D, Takeda K (2011) ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18. J Exp Med 208:1533-1546
74. Yuan Z, Gao S, Liu Q, Xia X, Liu X, Liu B, Hu R (2007) Toxoplasma gondii antibodies in cancer patients. Cancer Lett 254:71-74
75. Zhang YW, Halonen SK, Ma YF, Wittner M, Weiss LM (2001) Initial characterization of CST1, a Toxoplasma gondii cyst wall glycoprotein. Infect Immun 69:501-507
76. Zhang Z, Ojo KK, Johnson SM, Larson ET, He P, Geiger JA, Castellanos-Gonzalez A, White AC Jr, Parsons M, Merritt EA, Maly DJ, Verlinde CL, Van Voorhis WC, Fan E (2012) Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1. Bioorg Med Chem Lett 22:5264-5267